TP53 and gastric cancer: We herein present another case of GC with the co-existence of EBV-positive and -negative components and we performed various molecular analyses (TP53 sequencing, targeted next generation sequencing, and HER2 and C-MYC ISH) of the EBV-positive and -negative components in order to clarify their histogenesis.